121 related articles for article (PubMed ID: 628992)
1. Plasma testosterone in patients receiving diethylstilbestrol.
Beck PH; McAnich JW; Goebel JL; Stutzman RE
Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
[TBL] [Abstract][Full Text] [Related]
2. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
3. Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.
Prout GR; Kliman B; Daly JJ; MacLaughlin RA; Griffin PP; Young HH
Urology; 1976 Feb; 7(2):148-55. PubMed ID: 1246784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.
Sharifi R; Lee M; Ojeda L; Ray P; Stobnicki M; Guinan P
Urology; 1985 Aug; 26(2):117-24. PubMed ID: 3927551
[TBL] [Abstract][Full Text] [Related]
5. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
[No Abstract] [Full Text] [Related]
6. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
Mackler MA; Liberti JP; Smith MJ; Prout GR
Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
[No Abstract] [Full Text] [Related]
7. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.
Geller J; Albert JD; Nachtsheim DA; Loza D
J Urol; 1984 Oct; 132(4):693-6. PubMed ID: 6471215
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic prostate cancer. Factors that influence treatment selection and methods to increase acceptance of orchiectomy.
Merrill DC
Urology; 1988 Nov; 32(5):408-12. PubMed ID: 3188303
[TBL] [Abstract][Full Text] [Related]
9. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
Geller J; Albert J; Yen SS; Geller S; Loza D
J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of castration versus intravenous estrogen therapy in producing rapid endocrine control of metastatic cancer of the prostate.
Maatman TJ; Gupta MK; Montie JE
J Urol; 1985 Apr; 133(4):620-1. PubMed ID: 3981712
[TBL] [Abstract][Full Text] [Related]
11. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
12. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
Russo P; Liguori G; Heston WD; Huryk R; Yang CR; Fair WR; Whitmore WF; Herr HW
Cancer Res; 1987 Nov; 47(22):5967-70. PubMed ID: 3664500
[TBL] [Abstract][Full Text] [Related]
13. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.
Robinson MR; Thomas BS
Br Med J; 1971 Nov; 4(5784):391-4. PubMed ID: 5124437
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
[TBL] [Abstract][Full Text] [Related]
16. Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma.
Kent JR; Bischoff AJ; Arduino LJ; Mellinger GT; Byar DP; Hill M; Kozbur X
J Urol; 1973 May; 109(5):858-60. PubMed ID: 4699685
[No Abstract] [Full Text] [Related]
17. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
Geller J
Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy.
Alder A; Burger H; Davis J; Dulmanis A; Hudson B; Sarfaty G; Straffon W
Br Med J; 1968 Jan; 1(5583):28-30. PubMed ID: 5636740
[No Abstract] [Full Text] [Related]
19. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07.
Pilepich MV; Krall JM; John MJ; Rubin P; Porter AT; Marcial VA; Martz KL
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):813-7. PubMed ID: 2646266
[TBL] [Abstract][Full Text] [Related]
20. Subcapsular orchidectomy for carcinoma of the prostate.
Clark P; Houghton L
Br J Urol; 1977 Oct; 49(5):419-25. PubMed ID: 588938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
